Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
c-Fos mRNA is the transcript of the FOS proto-oncogene, which encodes the c-Fos protein, a critical component of the AP-1 transcription factor complex. As an immediate early gene (IEG), its mRNA is rapidly and transiently induced in response to a wide array of extracellular stimuli, including growth factors, cytokines, and neurotransmitters (2.2.2, 2.3.3). In the central nervous system, the induction of c-Fos mRNA serves as a hallmark of neuronal activation and is essential for processes such as synaptic plasticity and memory consolidation (2.3.5, 3.3.5). Pathologically, elevated levels of c-Fos mRNA are associated with oncogenic transformation and the progression of various cancers, as well as neurological conditions like epilepsy and Alzheimer's disease (2.3.1, 2.4.1). Therapeutic interventions targeting c-Fos mRNA, such as antisense oligonucleotides and siRNA, aim to downregulate its expression to mitigate pathological cell growth or aberrant neuronal activity (2.4.1, 3.2.1).
Antisense inhibition of translation, RNA interference (RNAi)-mediated degradation, and ribozyme-mediated cleavage of the mRNA transcript.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene c-Fos messenger RNA (c-Fos mRNA).